Sort
21,453 grants matching “tuberculosis”
Improving rapid phenotypic drug susceptibility testing for drug resistant tuberculosis in high-burden areas
$956,440Jordi B Torrelles · Texas Biomedical Research Institute · R01 · FY2023 · AI
Real-time surveillance to support dynamic and predictive models of MDR/XDR TB
$956,346Megan B Murray · Brigham And Women'S Hospital · U19 · FY2011 · AI
Closing -TB GAPs - for people living with HIV: TB Guidance for Adaptable Patient-Centered Service
$955,181Anna M Mandalakas · Baylor College Of Medicine · U01 · FY2023 · GH
Developing a Multivalent Subunit Particle Vaccine Against Tuberculosis
$955,150Jonathan F Lovell · State University Of New York At Buffalo · R33 · FY2025 · AI
Tb-FISH (Fluorescent in Situ Hybridization) Assay for Direct Detection of M. tube
$955,026Jyotsna S Shah · Id Fish Technology, Inc. · R44 · FY2010 · AI
Evolvable 'Resistance-Proof' Therapies
$955,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2015 · DE
Evolvable 'Resistance-Proof' Therapies
$955,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2013 · DE
Evolvable 'Resistance-Proof' Therapies
$955,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2017 · DE
Evolvable 'Resistance-Proof' Therapies
$955,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2014 · DE
Evolvable 'Resistance-Proof' Therapies
$955,000Leor S Weinberger · J. David Gladstone Institutes · DP1 · FY2016 · DE
Rapid DPP test for tuberculosis
$954,948Konstantin P Lyashchenko · Chembio Diagnostic Systems, Inc. · R44 · FY2012 · AI
Phase I Trial of Tuberculosis Vaccine - VTEU
$954,161Patricia Winokur · University Of Iowa · N01 · FY2015 · AI
Project 1 UIC Targeting Protein Degradation ClpC1 ATPase
$953,949Scott G. Franzblau · Global Alliance For Tb Drug Development · U19 · FY2021 · AI
AIDS International Training and Research Program
$953,630Carey Farquhar · University Of Washington · D43 · FY2007 · TW
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
$953,477Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2024 · AI
Core 1: Facility Management, Maintenance and Operations Core
$953,343Colin S. Duckett · Duke University · UC7 · FY2024 · AI
An Integrated Tabletop Platform for Rapid Detection of XDR-TB in Clinical Samples
$953,173Timothy Charles Rodwell · University Of California, San Diego · R01 · FY2018 · AI
Clinical Interventional Studies of HIV Reservoirs
$953,104Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Large Scale T Cell Epitope Discovery: Proteome-wide characterization of T cell epitopes from Mycobacterium tuberculosis in vaccination and active infection
$952,615Bjoern Peters · La Jolla Institute For Immunology · N01 · FY2022 · AI
(CIRCADIAN) Circadian Disruption as Mediator of Cardiometabolic Risk in Air Pollution
$952,577Sanjay Rajagopalan · Case Western Reserve University · R35 · FY2024 · ES
Epidemiology of Mycobacterial Infections
$952,553D. Rebecca Prevots · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
TUBERCULOSIS ELIMINATION AND LABORATORY
$952,232Barry Dickman · Philadelphia Departmentof Public Health · U52 · FY2008 · PS
Multiplexed Antigen-Specific Antibody Fc Profiling on a Chip for Point-of-Care Diagnosis of TB in HIV-infected Children
$951,462Bryan David Bryson · Massachusetts General Hospital · R01 · FY2022 · AI
Project 1: Mechanisms of Disease Progression
$951,210Alan A Aderem · Seattle Children'S Hospital · U19 · FY2022 · AI
An adjuvant that promotes TH1/TH17 and CD8 T cells in a tuberculosis vaccine
$951,064Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · AI